This report examines the clinical utility of genetic testing for hereditary hemorrhagic telangiectasia (HHT) in pediatric and adult patients who are symptomatic for HHT and/or have a family history of HHT. The evidence for the use of genetic testing is evaluated in symptomatic and asymptomatic individuals with a family history of HHT, with respect to medical management, testing at-risk family members, and confirmation of diagnosis.

If you have a Hayes login, click here to view the full report on the Knowledge Center.